Chat with us
Research Assistance
Online
  • Please enter your first name.

Europe Radiotheranostics Market Size & Outlook, 2026-2033

The radiotheranostics market in Europe is expected to reach a projected revenue of US$ 6,736.4 million by 2033. A compound annual growth rate of 10.4% is expected of Europe radiotheranostics market from 2026 to 2033.

  • Pharmaceuticals
    • Radiotherapy/Nuclear Medicine
      • Radiotheranostics Market Outlook
Revenue, 2025 (US$M)
$2,910.2
Estimate, 2026 (US$M)
$3,372.2
Forecast, 2033 (US$M)
$6,736.4
CAGR, 2026 - 2033
10.4%
Europe Radiotheranostics Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the radiotheranostics market

Every figure cited from GVR research

Europe radiotheranostics market highlights

  • The Europe radiotheranostics market generated a revenue of USD 2,910.2 million in 2025.
  • The market is expected to grow at a CAGR of 10.4% from 2026 to 2033.
  • In terms of segment, lutetium-177 was the largest revenue generating radioisotope in 2025.
  • 18F with Y-90 is the most lucrative radioisotope segment registering the fastest growth during the forecast period.
  • Country-wise, Norway is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 2,910.2 million
Market revenue in 2033USD 6,736.4 million
Growth rate10.4% (CAGR from 2026 to 2033)
Largest segmentLutetium-177
Fastest growing segment18F with Y-90
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationIodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90


Other key industry trends

  • In terms of revenue, Europe region accounted for 24.7% of the global radiotheranostics market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Europe is the fastest growing regional market and is projected to reach USD 6,736.4 million by 2033.

No credit card required*

Publish Date: Jan 21, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiotheranostics Market Companies

NameProfile# EmployeesHQWebsite
Bayer AGView profile 99,723Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368www.bayer.com
IsoRayView profile 51-100Richland, Washington, United States, North Americaisoray.com/
Point BiopharmaView profile 101-250Indianapolis, Indiana, United States, North Americawww.pointbiopharma.com/
Novartis AGView profile ---
Lantheus HoldingsView profile 501-1000North Billerica, Massachusetts, United States, North Americawww.lantheus.com/
Telix PharmaceuticalsView profile 251-500Melbourne, Victoria, Australia, Oceaniawww.telixpharma.com
Actinium PharmaceuticalsView profile 11-50New York, New York, United States, North Americawww.actiniumpharmaceuticals.com
RadioMedixView profile 11-50Houston, Texas, United States, North Americaradiomedix.com/
SHINE TechnologiesView profile 251-500Janesville, Wisconsin, United States, North Americawww.shinefusion.com
NorthStar Medical RadioisotopesView profile 251-500Madison, Wisconsin, United States, North Americawww.northstarnm.com/

Europe Radiotheranostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Radiotheranostics Market Outlook will help companies and investors design strategic landscapes.


Lutetium-177 was the largest segment with a revenue share of 41.67% in 2025.

Horizon Databook has segmented the Europe radiotheranostics market based on iodine-131, iodine-123, gallium-68, lutetium-177, 18f with y-90 covering the revenue growth of each sub-segment from 2021 to 2033.


  • Europe Radiotheranostics Market Radioisotope Outlook (Revenue, USD Million , 2021-2033)
    • Iodine-131
    • Iodine-123
    • Gallium-68
    • Lutetium-177
    • 18F with Y-90
    • Others
  • Europe Radiotheranostics Market Approach Outlook (Revenue, USD Million , 2021-2033)
    • Targeted Therapeutic
    • Targeted Diagnostic
  • Europe Radiotheranostics Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Oncology
    • Non-Oncology

Reasons to subscribe to Radiotheranostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Radiotheranostics Market Outlook databook

  • Our clientele includes a mix of Radiotheranostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Radiotheranostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Radiotheranostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Europe Radiotheranostics Market, 2021-2033 (US$M)

No Access Stack Chart

Europe radiotheranostics market statistics, by radioisotope, 2021-2033 (US$M)

No Access Pie Chart

Europe radiotheranostics market statistics, by country, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more